0 byCreativ Ceutical in posted on08/08/2019 Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN(R)) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies Read More No Comments
0 byCreativ Ceutical in posted on08/08/2019 Drug utilization patterns and healthcare resource use and costs in patients with neurogenic bladder in the United Kingdom: A retrospective primary care database study Read More No Comments
0 byCreativ Ceutical in posted on08/08/2019 Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan Read More No Comments
0 byCreativ Ceutical in posted on08/08/2019 Management and clinical practice of multiple face and scalp actinic keratosis in France Read More No Comments
0 byCreativ Ceutical in posted on08/08/2019 The Burden of Allergic Rhinitis and Impact of GRAZAX® Grass Allergy Immunotherapy Treatment on Quality of Life in Germany and The Netherlands: Results from A Qualitative Study Read More No Comments
0 byCreativ Ceutical in posted on08/08/2019 Measuring the health-related quality of life in young children: how far have we come? Read More No Comments
0 byCreativ Ceutical in posted on08/08/2019 Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective Read More No Comments
0 byCreativ Ceutical in posted on08/08/2019 Treatment patterns, persistence and adherence rates in patients with type 2 diabetes mellitus in Japan: a claims-based cohort study Read More No Comments
0 byCreativ Ceutical in posted on08/08/2019 Heterogeneous Recommendations for Oncology Products Among Different HTA Systems: A Comparative Assessment Read More No Comments
0 byCreativ Ceutical in posted on08/08/2019 A systematic literature review identifying associations between outcomes and quality of life (QoL) or healthcare resource utilisation (HCRU) in schizophrenia Read More No Comments
